Dharma Polimetal Future Growth
Future criteria checks 2/6
Dharma Polimetal is forecast to grow earnings and revenue by 15.5% and 8.8% per annum respectively. EPS is expected to grow by 14.9% per annum. Return on equity is forecast to be 24.4% in 3 years.
Key information
15.5%
Earnings growth rate
14.9%
EPS growth rate
| Auto Components earnings growth | 17.2% |
| Revenue growth rate | 8.8% |
| Future return on equity | 24.4% |
| Analyst coverage | Low |
| Last updated | 03 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6,618,333 | 750,000 | 504,000 | 1,007,500 | 3 |
| 12/31/2025 | 6,077,750 | 669,750 | 567,000 | 897,500 | 4 |
| 12/31/2024 | 5,498,875 | 580,250 | 416,667 | 789,000 | 4 |
| 6/30/2024 | 5,356,228 | 502,956 | 289,351 | 734,188 | N/A |
| 3/31/2024 | 5,434,478 | 529,103 | 260,056 | 747,019 | N/A |
| 12/31/2023 | 5,541,171 | 611,752 | 406,199 | 846,782 | N/A |
| 9/30/2023 | 5,492,236 | 663,637 | 332,120 | 769,720 | N/A |
| 6/30/2023 | 5,055,530 | 596,406 | 230,478 | 659,714 | N/A |
| 3/31/2023 | 4,431,536 | 494,303 | 31,510 | 511,401 | N/A |
| 12/31/2022 | 3,905,415 | 394,167 | -156,892 | 269,007 | N/A |
| 9/30/2022 | 3,493,330 | 404,148 | -258,357 | 295,162 | N/A |
| 6/30/2022 | 3,196,638 | 345,781 | -233,323 | 258,748 | N/A |
| 3/31/2022 | 3,153,454 | 364,824 | -140,437 | 275,278 | N/A |
| 12/31/2021 | 2,913,263 | 301,143 | -173,210 | 244,323 | N/A |
| 9/30/2021 | 2,569,490 | 172,727 | -85,195 | 173,027 | N/A |
| 6/30/2021 | 2,288,238 | 150,558 | -114,615 | 208,753 | N/A |
| 3/31/2021 | 2,103,725 | 87,475 | -67,399 | 216,810 | N/A |
| 12/31/2020 | 1,874,640 | 18,906 | -90,584 | 228,425 | N/A |
| 12/31/2019 | 2,729,393 | 170,713 | 9,674 | 235,743 | N/A |
| 12/31/2018 | 2,452,403 | 120,399 | 50,477 | 176,048 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DRMA's forecast earnings growth (15.5% per year) is above the savings rate (6.8%).
Earnings vs Market: DRMA's earnings (15.5% per year) are forecast to grow slower than the ID market (18.4% per year).
High Growth Earnings: DRMA's earnings are forecast to grow, but not significantly.
Revenue vs Market: DRMA's revenue (8.8% per year) is forecast to grow slower than the ID market (9.3% per year).
High Growth Revenue: DRMA's revenue (8.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DRMA's Return on Equity is forecast to be high in 3 years time (24.4%)